Literature DB >> 18550674

The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender.

James M Hill1, Melvyn J Ball, Donna M Neumann, Ann M Azcuy, Partha S Bhattacharjee, Saadallah Bouhanik, Christian Clement, Walter J Lukiw, Timothy P Foster, Manish Kumar, Herbert E Kaufman, Hilary W Thompson.   

Abstract

The purpose of this study was to determine the presence and copy numbers of herpes simplex virus type 1 (HSV-1) DNA in human trigeminal ganglia (TG) with respect to age, gender, and postmortem interval (PMI). Human TG (n = 174, obtained from the Oregon Brain Bank, with data on age, gender, and PMI) were analyzed for HSV-1 DNA copies (HSV-1 DNA polymerase gene) by using real-time PCR. We found that 89.1% (131/147) of subjects and 90.1% (155/174) of TG contained HSV-1 DNA. The copy numbers of HSV-1 DNA in the positives ranged from very high (>10(6)) to very low (5). These data confirm and strengthen our previous findings that subjects were positive for HSV-1 DNA in tears (46/50; 92%) and saliva (47/50; 94%). These TG data and tear and saliva data demonstrated considerable variability in copy numbers of HSV-1 DNA per subject. Statistical analysis showed no significant relationship between gender and copy number, age and copy number, or PMI and copy number for each pair of variables. A factorial analysis of gender, age, and PMI with respect to copy number also showed no statistical significance. This is the first study that provides statistical analysis that documents that the prevalence of HSV-1 DNA in the human TG is not a function of either gender or age.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550674      PMCID: PMC2519549          DOI: 10.1128/JVI.00686-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Wide variations in herpes simplex virus type 1 inoculum dose and latency-associated transcript expression phenotype do not alter the establishment of latency in the rabbit eye model.

Authors:  J E O'Neil; J M Loutsch; J S Aguilar; J M Hill; E K Wagner; D C Bloom
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

2.  The efficiency of simulation-based multiple comparisons.

Authors:  D Edwards; J J Berry
Journal:  Biometrics       Date:  1987-12       Impact factor: 2.571

3.  High-dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivation.

Authors:  G C Perng; H Ghiasi; S M Slanina; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

4.  Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits.

Authors:  J M Hill; M A Rayfield; Y Haruta
Journal:  Curr Eye Res       Date:  1987-01       Impact factor: 2.424

5.  Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans.

Authors:  S Efstathiou; A C Minson; H J Field; J R Anderson; P Wildy
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

6.  Quantitation of herpes simplex virus type 1 DNA and latency-associated transcripts in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency.

Authors:  J M Hill; B M Gebhardt; R Wen; A M Bouterie; H W Thompson; R J O'Callaghan; W P Halford; H E Kaufman
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

7.  Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue.

Authors:  W Liedtke; B Opalka; C W Zimmermann; E Lignitz
Journal:  J Neurol Sci       Date:  1993-05       Impact factor: 3.181

8.  Tissue pH as an indicator of mRNA preservation in human post-mortem brain.

Authors:  A E Kingsbury; O J Foster; A P Nisbet; N Cairns; L Bray; D J Eve; A J Lees; C D Marsden
Journal:  Brain Res Mol Brain Res       Date:  1995-02

Review 9.  Asymptomatic shedding of herpes simplex virus (HSV) in the oral cavity.

Authors:  Craig S Miller; Robert J Danaher
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2007-08-20

10.  Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia.

Authors:  R Mahalingam; M C Wellish; A N Dueland; R J Cohrs; D H Gilden
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

View more
  38 in total

1.  Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study.

Authors:  Konasale M Prasad; Shaun M Eack; Dhruman Goradia; Krishna M Pancholi; Matcheri S Keshavan; Robert H Yolken; Vishwajit L Nimgaonkar
Journal:  Am J Psychiatry       Date:  2011-06-01       Impact factor: 18.112

2.  A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion.

Authors:  Vaibhav Tiwari; Shripaad Y Shukla; Deepak Shukla
Journal:  Antiviral Res       Date:  2009-08-07       Impact factor: 5.970

3.  Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.

Authors:  Sarah Samandary; Hédia Kridane-Miledi; Jacqueline S Sandoval; Zareen Choudhury; Francina Langa-Vives; Doran Spencer; Aziz A Chentoufi; François A Lemonnier; Lbachir BenMohamed
Journal:  Hum Immunol       Date:  2014-05-04       Impact factor: 2.850

4.  Real-time polymerase chain reaction for the diagnosis of necrotizing herpes stromal keratitis.

Authors:  Jun-Xin Ma; Lin-Nong Wang; Ru-Xia Zhou; Yang Yu; Tong-Xin Du
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

5.  Efficient generation and rapid isolation via stoplight recombination of Herpes simplex viruses expressing model antigenic and immunological epitopes.

Authors:  Rebecca L Sanchez; Alistair J Ramsay; Timothy P Foster
Journal:  J Virol Methods       Date:  2011-10-20       Impact factor: 2.014

6.  A double-blind placebo-controlled study to evaluate valacyclovir alone and with aspirin for asymptomatic HSV-1 DNA shedding in human tears and saliva.

Authors:  Manish Kumar; James M Hill; Christian Clement; Emily D Varnell; Hilary W Thompson; Herbert E Kaufman
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-15       Impact factor: 4.799

7.  Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.

Authors:  Maria Dulfary Sanchez; Augusto C Ochoa; Timothy P Foster
Journal:  Antiviral Res       Date:  2016-05-15       Impact factor: 5.970

Review 8.  Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiology.

Authors:  Melvyn J Ball; Walter J Lukiw; Eli M Kammerman; James M Hill
Journal:  Alzheimers Dement       Date:  2012-11-14       Impact factor: 21.566

Review 9.  HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain.

Authors:  J R Goss; M S Gold; J C Glorioso
Journal:  Gene Ther       Date:  2009-04       Impact factor: 5.250

10.  HSV, axonal transport and Alzheimer's disease: in vitro and in vivo evidence for causal relationships.

Authors:  Elaine L Bearer
Journal:  Future Virol       Date:  2012-09       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.